The latest research study “Atopic Dermatitis Market Size: Epidemiology, Industry Trends, Share, Growth, Opportunity, and Forecast 2023-2033″ provides an exhaustive analysis of the atopic dermatitis market. The increasing prevalence of dermatological disorders caused by epidermal gene mutations, complex interactions of immune dysregulation, and environmental factors that disrupt the epidermis resulting in intensely pruritic skin lesions is primarily driving the global atopic dermatitis market.
Atopic dermatitis refers to a type of non-communicable eczema in which the skin barrier becomes dry and irritated. Though this ailment is more frequent among children, it can also affect individuals of any age. Some of the common symptoms include dry or hypersensitive skin, rough, leathery, or scaly skin, inflamed or discolored skin, swelling in the afflicted area, oozing or blistering of the skin, etc. In line with this, there are various conditions that might resemble atopic dermatitis.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a free sample brochure: https://www.imarcgroup.com/atopic-dermatitis-market/requestsample
Atopic Dermatitis Market Trends and Drivers:
The growing prevalence of dermatological disorders caused by epidermal gene mutations, complex interactions of immune dysregulation, and environmental factors that disrupt the epidermis resulting in intensely pruritic skin lesions, is among the key factors stimulating the atopic dermatitis market. Moreover, the increasing incidences of food and skin allergies among infants are acting as significant growth-inducing factors. Besides this, the expanding geriatric population, who are susceptible to developing eczema, is positively influencing the global market. Furthermore, the widespread adoption of oral corticosteroids for severe cases when the disease has covered large areas of the body or in case of any complication with other therapies is also propelling the market growth. Apart from this, the inflating popularity of ultraviolet phototherapy as a second-line intervention for both chronic and acute atopic dermatitis is further bolstering the global market. Additionally, the escalating demand for novel biologics, owing to their high efficacy, safety, targeted approach to treating the disease, etc., is anticipated to fuel the atopic dermatitis market over the forecasted period.
Click here to view detailed information with table of content: https://www.imarcgroup.com/atopic-dermatitis-market
Atopic Dermatitis Market Report Segmentation:
The report has been segmented the market into following categories:
Time Period of the Study
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Covered
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the atopic dermatitis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the atopic dermatitis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current atopic dermatitis marketed drugs and late-stage pipeline drugs.
In-Market Drugs
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Late-Stage Pipeline Drugs
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Regulatory status
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
